(Q44347699)

2 December 2017

Naltrexone pharmacotherapy for opioid dependent federal probationers (English)

1 reference

2 December 2017

0 references

0 references

0 references

Cornish JW

1

1 reference

2 December 2017

Metzger D

2

1 reference

2 December 2017

Woody GE

3

1 reference

2 December 2017

Wilson D

4

1 reference

2 December 2017

McLellan AT

5

1 reference

2 December 2017

Vandergrift B

6

1 reference

2 December 2017

O'Brien CP

7

1 reference

2 December 2017

1 November 1997

1 reference

Journal of Substance Abuse Treatment

2 December 2017

1 reference

2 December 2017

14

1 reference

2 December 2017

529-534

1 reference

2 December 2017

6

1 reference

Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation.

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Controlled clinical study of naltrexone side effects comparing first-day doses and maintenance regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

One-year follow-up status of treatment-seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Predictors of favorable outcome following naltrexone treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Naltrexone treatment of heroin addiction: one-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

The Clinical Usefulness of Narcotic Antagonists: Preliminary Findings on the Use of Naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Narcotic antagonist treatment: clinical experience with naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Clinical Experience with Naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Psychological Approaches for the Treatment of Cocaine Dependence-A Neurobehavioral Approach

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Clinical Use of Naltrexone (EN-1639A): Part I: Safety and Efficacy in Pilot Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

The efficacy of naltrexone in preventing reabuse of heroin after detoxification.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

Successful use of naltrexone in addicted physicians and business executives.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2897%2900020-2

7 January 2021

10.1016/S0740-5472(97)00020-2

Identifiers

DOI

1 reference

2 December 2017

1 reference